Sort
64,565 grants matching “drug discovery”
UIC: In vitro In vivo Mtb Pharmacology
$1,007,216Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2020 · AI
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,007,191Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Human Translational Studies of Vascular Thrombosis and Inflammation
$1,007,129Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Obstetric Pharmacology Research Units Network Center at UTMB-Galveston
$1,007,037Gary D Hankins · University Of Texas Med Br Galveston · U10 · FY2010 · HD
Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH
$1,006,870Fakhrul Ahsan · Vascular Biosciences · R42 · FY2022 · HL
Small Molecule Screening and Medicinal Chemistry Core
$1,006,850Stephen Lory · Harvard Medical School · U54 · FY2013 · AI
MGNet Administrative Core
$1,006,465Henry J Kaminski · George Washington University · U54 · FY2022 · NS
Novel Sample Introduction Methodologies for Molecular Rotational Resonance (MRR) Spectroscopy
$1,006,315Voislav Blagojevic · Brightspec, Inc. · R44 · FY2023 · GM
Novel Small-Molecule Therapies for CF
$1,006,208Alan S Verkman · University Of California, San Francisco · P30 · FY2017 · DK
TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP
$1,006,199Southern Research Institute · U19 · FY2001 · CA
DISCOVERY OF NOVEL DRUGS FOR ALZHEIMERS DISEASE
$1,006,151University Of Florida · P01 · FY2001 · AG
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model Disease
$1,006,126Joseph Vincent Bonventre · Brigham And Women'S Hospital · UH3 · FY2020 · TR
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model Disease
$1,006,126Joseph Vincent Bonventre · Brigham And Women'S Hospital · UH3 · FY2021 · TR
PDE4B Inhibitors For Treating Major Depression
$1,006,069Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2015 · MH
Development of ultra-efficient antibodies for single cell mapping applications
$1,006,054Andrea Lynn Johnstone · Epicypher, Inc. · R44 · FY2024 · AI
New Quantitative Neuroimaging Metrics of Structural and Functional Connectivity of the Locus Coeruleus as a Novel Biomarker of Alzheimer's Disease Pathogenesis and Progression
$1,006,046Lawrence R. Frank · University Of California, San Diego · R01 · FY2021 · AG
An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids
$1,006,032Fred Etoc · Rumi Scientific, Inc. · R44 · FY2024 · MH
The MetaCyc & BioCyc Pathway/Genome Databases
$1,005,713Peter D Karp · Sri International · R01 · FY2019 · GM
The MetaCyc & BioCyc Pathway/Genome Databases
$1,005,713Peter D Karp · Sri International · R01 · FY2020 · GM
The MetaCyc & BioCyc Pathway/Genome Databases
$1,005,713Peter D Karp · Sri International · R01 · FY2021 · GM
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,005,497Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,005,497Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
Biomarker and Diagnostic Discovery for Inborn Errors of Metabolism
$1,005,457Iman Famili · Gt Life Sciences, Inc. · R44 · FY2011 · DK
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,005,422Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Assay Development and High Throughput Screening Core
$1,005,304Zhong-Yin Zhang · Indiana University Indianapolis · U54 · FY2021 · AG